Zoetis Inc (ZTS)
149.22
-1.61
(-1.07%)
USD |
NYSE |
Apr 15, 16:00
149.22
0.00 (0.00%)
Pre-Market: 07:37
Zoetis Enterprise Value: 71.40B for April 15, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pfizer Inc | 170.64B |
| Supernus Pharmaceuticals Inc | 1.302B |
| Eli Lilly and Co | 710.38B |
| Merck & Co Inc | 221.50B |
| Gilead Sciences Inc | 146.67B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 581.00M |
| Revenue (Quarterly) | 2.317B |
| Total Expenses (Quarterly) | 1.552B |
| EPS Diluted (Quarterly) | 1.29 |
| Gross Profit Margin (Quarterly) | 69.49% |
| Profit Margin (Quarterly) | 25.08% |
| Earnings Yield | 3.67% |
| Operating Earnings Yield | 5.00% |
| Normalized Earnings Yield | 3.831 |